Live
ScienceLaser-boosted microscopes could reveal new drug targets, sharpen views inside cellsScienceThe ocean current that warms Europe may be more resilient than fearedFierceBiotechAI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data findsClinical OMICsRemote Monitoring Benefits Unclear After Hospitalization for Serious InfectionFierceBiotechNovo reports data breach, tells clinical trial patients to 'remain vigilant'Endpoints NewsThe seeming inevitability of rising healthcare costsFierceBiotechPredicta links with Spanish university to offer diagnostic for blood cancersBioPharma DiveSummit pulls $500M share sale a day after announcing itEndpoints NewsDrugmakers are turning to logistics providers as trade disruptions linger, DHL exec saysBioPharma DiveSensorion, citing Regeneron competition, shifts focus to a different hearing loss therapyEndpoints NewsSummit withdraws $500M offering, citing 'market conditions'BioWorldScore in phase I CML trial has Enliven looking ahead to phase III
Contenu indisponible. Consultez la source originale.